| CLASS | PANEL.DRUG/TOX | LP29683-7 |
| COMPONENT | Vedolizumab & Vedolizumab Ab panel | LP269307-7 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Vedolizumab and Vedolizumab Ab panel | Serum or Plasma | Drug and Toxicology Panels | LP392134-5 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Order | |
| PanelType | Panel |
| LONG_COMMON_NAME | en-US | Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma |
| LONG_COMMON_NAME | en-US | Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma |
| SHORTNAME | en-US | Vedol + Vedol Ab Pnl SerPl-mCnc |
| ConsumerName | en-US | Vedolizumab and Vedolizumab Ab panel, Blood |
| LONG_COMMON_NAME | fr-FR | Védolizumab et védolizumab anticorps panel [Masse/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | es-MX | Panel de Vedolizumab y Vedolizumab Ab: Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77
FHIR